glp-1 insulin The Physiology of Glucagon-like Peptide 1 | Physiological Reviews Frontiers | GLP−1 receptor agonists
Description
Understanding the differences between tirzepatide and retatrutide helps set realistic expectations about what each medication offers and when the next generation will actually be accessible
Additional details can be made available upon reasonable request to the corresponding author.
These effects are mainly driven by the reduction of albuminuria
Draw up insulin
A meta-analysis summarized the results of these randomized trials, showing a significant reduction in MACEs, CV death, stroke, myocardial infarction, death from all causes, heart failure, and kidney disease, emphasizing the important glycometabolic effects and extraglycemic actions that would determine a significant clinical benefit in patients with T2DM [40]
The postprandial actions of GLP-1 receptor agonists: the missing link for cardiovascular and kidney protection in type 2 diabetes
